Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury
Autor: | Peter R. Mertens, Jean-Claude Dussaule, Ute Raffetseder, Monique Kerroch, Clemens D. Cohen, Annemarie Dittrich, Sonja Djudjaj, Sabine Brandt, Cheng Zhu, Maja T. Lindenmeyer, Dominique Guerrot, Jürgen Floege, Peter Boor, Christos Chatziantoniou, Lydia Hanssen, Tammo Ostendorf |
---|---|
Přispěvatelé: | Department of Nephrology and Immunology, Rheinisch-Westfälische Technische Hochschule Aachen (RWTH), Department of Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University [Magdeburg] (OVGU), Remodelage et Reparation du Tissu Renal, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Pathology, Institute of Molecular Biomedicine, Comenius University in Bratislava, Department of Medical Microbiology, Division of nephrology and Institute of Physiology, Universität Zürich [Zürich] = University of Zurich (UZH), This work was supported by fellowship grants from the ERA-ETDA (to S.D.), DFG SFB 854 project 01 (to P.R.M.) and DFG Sachbeihilfeantrag 1365/7-1 (to P.R.M.). C.C. received INSERM funding. U.R was funded by the Else-Kröner-Fresenius- Stiftung., Rheinisch-Westfälische Technische Hochschule Aachen University (RWTH), Otto-von-Guericke-Universität Magdeburg = Otto-von-Guericke University [Magdeburg] (OVGU) |
Rok vydání: | 2012 |
Předmět: |
MESH: Signal Transduction
MESH: Inflammation Pathology Receptor expression Nephron 030204 cardiovascular system & hematology MESH: Receptor Notch1 MESH: Mice Knockout [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology MESH: Biopsy 0302 clinical medicine MESH: Up-Regulation MESH: Animals chemotaxis Receptor 0303 health sciences Kidney Kidney diseases 3. Good health tubular cells medicine.anatomical_structure MESH: Fibrosis MESH: Membrane Proteins medicine.symptom MESH: Nephritis Interstitial medicine.medical_specialty MESH: Rats proliferation Notch signaling pathway Inflammation Biology Pathology and Forensic Medicine 03 medical and health sciences MESH: Mice Inbred C57BL MESH: Cell Proliferation medicine MESH: Intercellular Signaling Peptides and Proteins MESH: Mice MESH: Transforming Growth Factor beta 030304 developmental biology MESH: Humans urogenital system fibrosis Kidney metabolism MESH: Kidney medicine.disease MESH: Cell Line inflammation Notch receptors MESH: Ureteral Obstruction MESH: Disease Models Animal MESH: Receptors Notch MESH: Female Kidney disease |
Zdroj: | Journal of Pathology Journal of Pathology, Wiley, 2012, 228 (3), pp.286-99. ⟨10.1002/path.4076⟩ Journal of Pathology, 2012, 228 (3), pp.286-99. ⟨10.1002/path.4076⟩ |
ISSN: | 0022-3417 1096-9896 |
DOI: | 10.1002/path.4076 |
Popis: | International audience; Kidney diseases impart a vast burden on affected individuals and the overall health care system. Progressive loss of renal parenchymal cells and functional decline following injury are often observed. Notch-1 and -2 receptors are crucially involved in nephron development and contribute to inflammatory kidney diseases. We specifically determined the participation of receptor Notch-3 following tubulointerstitial injury and in inflammatory responses. Here we show by heat map analyses that Notch-3 transcripts are up-regulated in human kidney diseases. A similar response was corroborated with kidney cells following TGF-β exposure in vitro. The murine unilateral ureteral obstruction (UUO) model mirrors hallmarks of tubulointerstitial injury and damage. A subset of tubular and interstitial cells demonstrated up-regulated Notch-3 receptor expression in diseased animals. We hypothesized a relevance of Notch-3 receptors for the chemotactic response. To address this question, animals with genetic ablation of receptor Notch-3 were analysed following UUO. As a result, we found that Notch-3-deficient animals are protected from tubular injury and cell loss with significantly reduced interstitial collagen deposition. Monocytic cell infiltration was significantly reduced and retarded, likely due to abrogated chemokine synthesis. A cell model was set up that mimics enhanced receptor Notch-3 expression and activation. Here a pro-mitogenic response was seen with activated signalling in tubular cells and fibroblasts. In conclusion, Notch-3 receptor fulfils non-redundant roles in the inflamed kidney that may not be replaced by other Notch receptor family members. Thus, specific blockade of this receptor may be suitable as therapeutic option to delay progression of kidney disease. |
Databáze: | OpenAIRE |
Externí odkaz: |